Estradiol and Bisphenol A Stimulate Androgen Receptor and Estrogen Receptor Gene Expression in Fetal Mouse Prostate Mesenchyme Cells
Author(s) -
Catherine A. Richter,
Julia A. Taylor,
Rachel L. Ruhlen,
Wade V. Welshons,
Frederick S. vom Saal
Publication year - 2007
Publication title -
environmental health perspectives
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.257
H-Index - 282
eISSN - 1552-9924
pISSN - 0091-6765
DOI - 10.1289/ehp.9804
Subject(s) - endocrinology , medicine , mesenchyme , estrogen receptor , prostate , androgen receptor , estrogen , biology , endocrine disruptor , estrogen receptor alpha , androgen , xenoestrogen , estrogen receptor beta , gene expression , endocrine system , prostate cancer , hormone , gene , microbiology and biotechnology , mesenchymal stem cell , biochemistry , cancer , breast cancer
Hormonal alterations during development have lifelong effects on the prostate gland. Endogenous estrogens, including 17beta-estradiol (E(2)), and synthetic estrogenic endocrine disruptors, such as bisphenol A (BPA), have similar effects on prostate development. Increasing exposure to estrogens within the low-dose, physiologic range results in permanent increases in the size and androgen responsiveness of the prostate, whereas exposure within the high-dose, pharmacologic range has the opposite effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom